Thalassemias are emerging as a global public health concern. Due to remarkable success in the reduction of childhood mortality by controlling infectious diseases in developing countries, thalassemias are likely to be a major public health concern in the coming decades in South Asia. Despite the fact that Bangladesh lies in the world’s thalassemia belt, the information on different aspects (epidemiology, clinical course, mortality, complications and treatment outcomes) of thalassemias is lacking. In this comprehensive review, the aim is to to depict the epidemiological aspects of thalassemias, mutation profile and current treatment and management practices in the country by sharing the experience of dealing with 1178 cases over 2009–2014 time periods in a specialized thalassemia treatment centre. We have also discussed the preventative strategies of thalassemias from the context of Bangladesh which could be effective for other developing countries.
BackgroundChikungunya virus causes mosquito-transmitted infection that leads to extensive morbidity affecting substantial quality of life. Disease associated morbidity, quality of life, and financial loss are seldom reported in resources limited countries, such as Bangladesh. We reported the acute clinical profile, quality of life and consequent economic burden of the affected individuals in the recent chikungunya outbreak (May to September 2017) in Dhaka city, Bangladesh.MethodsWe conducted a cross-sectional study during the peak of chikungunya outbreak (July 24 to August 5, 2017) to document the clinical profiles of confirmed cases (laboratory test positive) and probable cases diagnosed by medical practitioners. Data related to clinical symptoms, treatment cost, loss of productivity due to missing work days, and quality of life during their first two-weeks of symptom onset were collected via face to face interview using a structured questionnaire. World Health Organization endorsed questionnaire was used to assess the quality of life.ResultsA total of 1,326 chikungunya cases were investigated. Multivariate analysis of major clinical variables showed no statistically significant differences between confirmed and probable cases. All the patients reported joint pain and fever. Other more frequently reported symptoms include headache, loss of appetite, rash, myalgia, and itching. Arthralgia was polyarticular in 56.3% of the patients. Notably, more than 70% patients reported joint pain as the first presenting symptom. About 83% of the patients reported low to very low overall quality of life. Nearly 30% of the patients lost more than 10 days of productivity due to severe arthropathy.ConclusionsThis study represents one of the largest samples studied so far around the world describing the clinical profile of chikungunya infection. Our findings would contribute to establish an effective syndromic surveillance system for early detection and timely public health intervention of future chikungunya outbreaks in resource-limited settings like Bangladesh.
Background: Thalassaemia is a potentially life-threatening yet preventable inherited hemoglobin disorder. Understanding local socio-cultural context and level of public awareness about thalassaemia is pivotal for selecting effective prevention strategies. This study attempted to assess knowledge and perceptions about thalassaemia among college students in Bangladesh. Methods: A supervised cross-sectional survey was conducted on 1578 college students using a self-administered structured questionnaire. The survey took place from 15 February 2018 to 17 March 2018 in the Jamalpur district in Bangladesh. Besides the attitude-related questions, the study asked a total of 12 knowledge-related questions, which were scored on a scale of 0-12 points. Results: Over two-thirds (67%) of the college students had never heard of thalassaemia. The urban-rural dichotomy was observed among those familiar with the term; (46.4% from urban vs. 25.8% from rural colleges). A similar pattern was observed for knowledge score; 5.07 ± 1.87 for students from the urban colleges compared to 3.69 ± 2.23 for rural colleges. Students from the science background had the highest knowledge score (5.03 ± 1.85), while those from arts and humanities background scored lowest (3.66 ± 2.3). Nearly 40% of the students were not sure or did not want to be a friend of a thalassaemia patient. Whereas 39% either declined or remained hesitant about helping thalassaemia patients by donating blood. However, most of the respondents (88%) showed a positive attitude towards 'premarital' screening to prevent thalassaemia. Conclusions: This study has identified critical knowledge gaps and societal misperceptions about thalassaemia. A better understanding of these aspects will be pivotal for disseminating thalassaemia related information. As the first study of this kind in Bangladesh, findings from this study has generated baseline data that would contribute to developing effective intervention strategies in Bangladesh and other countries with a comparable socio-cultural setting.
Dengue is a mosquito-borne viral disease commonly reported in the tropical regions of the world. The presence of two mosquito vectors (Aedes aegypti is highly urban, while A. albopictus is less urban) throughout the year makes dengue fever an endemic disease in a number of countries. Among the predicting variables, a rise of temperature and rainfall have shown to be associated with the number of dengue cases [1]. While relatively less emphasized compared to the climatic factors, mass movement is particularly important during large-scale outbreaks. This article presents a case based on the available data from the 2019 outbreak in Bangladesh, where the dengue fever was initially concentrated in Dhaka, the capital city. Dhaka is one of the most crowded megacities in the world, with over 19 million people distributed over 453 square km (spatial density of 41,000/square km) [2]. It is a hub of all key administrative, educational, and industrial activities in Bangladesh. Hence, a considerable proportion of the Bangladeshi population prefers to live in the city for better income, quality education, and better facilities overall. The 2019 dengue outbreak in Dhaka was the most intense since the emergence of dengue outbreaks in late the 1990s in Bangladesh [3]. According to Directorate General of Health Services (DGHS), Bangladesh, a total of 100,201 confirmed dengue cases were admitted in hospitals between January and December 2019; 51,179 cases were reported in Dhaka city and 49,022 across the rest of Bangladesh [4]. This implies a 10-fold increase in hospitalized cases compared with the largest outbreak before 2019. Since the first major outbreak in 2000, all four serotypes (DEN-1-4) were reported in Dhaka city until 2003, a with higher prevalence of DEN-3 serotype. After a hiatus (2013-2016), DEN-3 serotype re-emerged in 2017, and this serotype has been reported to be the most frequently identified during the 2019 outbreak [5,6]. Anecdotal evidence from medical practitioners suggests that dengue patients manifested with a spectrum of atypical symptoms in the 2019 outbreak, which can be related to serodiversity of the viral strains. A recently published nationwide seroprevalence study (2014-2015) showed that 24% of participants had past history of dengue infection in Bangladesh [7]. Seropositivity of the infected individuals was largely confined to three big cities, namely Dhaka, Chittagong, and Khulna, indicating that circulation of dengue virus was not high in the semi-urban and rural areas of Bangladesh [7]. Notably, all major dengue outbreaks in Bangladesh showed a tendency to remain confined mostly in Dhaka city [7], and the 2019 outbreak showed the same trend PLOS NEGLECTED TROPICAL DISEASES
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.